Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideLAROCCA, Alessandra; CAVALLO, Federica; PATRIARCA, Francesca et al.Blood. 2012, Vol 119, Num 4, pp 933-939, issn 0006-4971, 7 p.Article

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyCAVO, Michele; TACCHETTI, Paola; OFFIDANI, Massimo et al.Lancet (British edition). 2010, Vol 376, Num 9758, pp 2075-2085, issn 0140-6736, 11 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Primary plasma cell leukemia in the era of new drugs: Has something changed?MUSTO, Pellegrino; PAGANO, Livio; OMEDE, Paola et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 2, pp 141-149, issn 1040-8428, 9 p.Article